Press Release: EMEA-coordinated PROTECT project has been accepted for funding by the Innovative Medicines Initiative Joint Undertaking

The PROTECT project (Pharmacoepidemiological Research on Outcomes of Therapeutics by a European ConsorTium), in April 2009, was accepted for funding by the Innovative Medicines Initiative Joint Undertaking (IMIJU). PROTECT is a collaborative European project aiming to develop innovative methods in pharmacoepidemiology and pharmacovigilance. The European Medicines Agency (EMEA) coordinates the project and manages a multi-national consortium of 29 public and private partners.